ZCR-22961-99323
2 vaccinations
10 coded responses
12 check-ins
10 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 12-15
- ZIP prefix
- 721 / AR
- Registered
- 2021-07-13
- Relationship
- Child or adolescent in my care
- Guardian
- DP2-24961-62004
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-18
Dose 1 — Pfizer-BioNTech
-
2021-07-09
Dose 2 — Pfizer-BioNTech
-
2021-07-13
Registered in v-safe
-
2021-07-13
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Asthenia, Hypoaesthesia, Mobility decreased, Paraesthesia — Feeling: Poor · Site: Pain · Chills, Headache, Fatigue or tiredness, Vomiting, Rash, not including the immediate area around the injection site · Be unable to do their normal daily activitiesFree text: Weakness, inability to walk without assistance, numbness and tingling in legs and toesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-14
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Gait disturbance, Hypoaesthesia, Paraesthesia — Feeling: Poor · Chills, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do their normal daily activitiesFree text: Inability to walk without assistance, numbness in legs and tingling in toesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-15
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Gait inability, Hypoaesthesia, Muscle spasms, Paraesthesia — Feeling: Poor · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do their normal daily activitiesFree text: Inability to walk without assistance, numbness and tingling in legs and toes. Cramps in calvesMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-16
Survey response — day 7, dose 2, dependentMedDRA: Gait inability, Hypoaesthesia, Paraesthesia — Feeling: Poor · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do their normal daily activitiesFree text: Inability to walk without assistance, numbness and tingling in legs and toesMedDRA releases: 2024-11 · check-in free text available
-
2021-07-23
Survey response — day 14, dose 2, dependentMedDRA: Pain in extremity — Feeling: Poor · Be unable to do their normal daily activitiesFree text: Legs are painful at timesMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-07-30
-
2021-08-06
Survey response — day 28, dose 2, dependentMedDRA: Muscle spasms, Pain in extremity — Feeling: Fair · Be unable to do their normal daily activitiesFree text: Severe cramps and aching in legsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-15
Survey response — day 35, dose 2, dependentMedDRA: Fatigue, Muscle spasms — Feeling: Fair · Be unable to do their normal daily activitiesFree text: More severe cramps and fatigueMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-22
Survey response — day 42, dose 2, dependentMedDRA: Dizziness, Hypoaesthesia, Muscular weakness, Paraesthesia — Feeling: Poor · Be unable to work or attend school, Be unable to do their normal daily activitiesFree text: Extreme weakness in legs, numbness and tingling, dizzinessMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-08
Survey response — 3 months, dose 2, dependentMedDRA: Electric shock sensation, Fatigue — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Shocks through legs and extreme fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-01-07
Survey response — 6 months, dose 2, dependentMedDRA: Electric shock sensation — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Shocks that radiates down the left side of bodyMedDRA releases: 2024-11 · check-in free text available
- 2022-07-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-18 | Pfizer-BioNTech | No |
| 2 | 2021-07-09 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Weakness, inability to walk without assistance, numbness and tingling in legs and toes
Systemic reaction (other): Inability to walk without assistance, numbness in legs and tingling in toes
Systemic reaction (other): Inability to walk without assistance, numbness and tingling in legs and toes. Cramps in calves
Release 9 — day 7, dose 2, dependent
Systemic reaction (other): Inability to walk without assistance, numbness and tingling in legs and toes
Release 9 — day 14, dose 2, dependent
Symptoms: Legs are painful at times
Release 9 — day 28, dose 2, dependent
Symptoms: Severe cramps and aching in legs
Release 9 — day 35, dose 2, dependent
Symptoms: More severe cramps and fatigue
Release 9 — day 42, dose 2, dependent
Symptoms: Extreme weakness in legs, numbness and tingling, dizziness
Release 10 — 3 months, dose 2, dependent
Symptoms: Shocks through legs and extreme fatigue
Release 10 — 6 months, dose 2, dependent
Symptoms: Shocks that radiates down the left side of body
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | ✓ | · | ✓ |
| SD | Electric shock sensation | · | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Hypoaesthesia | ✓ | · | ✓ |
| SD | Muscle spasms | ✓ | · | ✓ |
| SD | Muscular weakness | ✓ | · | ✓ |
| SD | Pain in extremity | ✓ | · | ✓ |
| SD | Paraesthesia | ✓ | · | ✓ |
| SRO | Asthenia | ✓ | ✓ | ✓ |
| SRO | Gait disturbance | ✓ | ✓ | ✓ |
| SRO | Gait inability | ✓ | · | ✓ |
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Mobility decreased | ✓ | ✓ | ✓ |
| SRO | Muscle spasms | ✓ | · | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release